Curis | CRIS - Umsatzkosten





Umsatzkosten Veränderung Datum
Alaunos Therapeutics USD 0 18K 2024-09
Amgen USD 1.87B 271M 2026-06
AstraZeneca USD 2.52B 2.73B 2026-06
Bayer EUR 4.54B 692M 2026-06
Bristol-Myers Squibb USD 7.89B 4.03B 2026-06
CSL USD 3.87B 2.08B 2025-12
Curis USD 314K 9.96M 2025-12
Eli Lilly USD 3.27B 309M 2026-06
Exelixis USD 20.66M 704K 2026-06
Gilead Sciences USD 1000M 445M 2026-06
GlaxoSmithKline GBP 2.07B 192M 2026-06
Incyte USD 104.96M 457K 2026-06
Merck USD 3.14B 200M 2026-06
Novartis USD 3.71B 251M 2026-06
Pfizer USD 4.09B 498M 2026-06
Roche Holding CHF 7.85B 630M 2026-06
Sanofi EUR 3.02B 656M 2026-06
Takeda JPY 517.6B 42.94B 2026-06
TG Therapeutics USD 41.19M 7.68M 2026-06
Verastem USD 3.05M 159K 2026-03